Недавние обновления
- Cardiovascular Disease Preclinical Research: Recent UpdateAce Therapeutics, a contract research organization engaged in cardiovascular disease research, is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. Cardiovascular disease (CVD) remains a...0 Комментарии 0 Поделились 746 Просмотры 0 предпросмотрВойдите, чтобы отмечать, делиться и комментировать!
- The Role of ADME/DMPK in Stroke Drug DevelopmentDrug metabolism and pharmacokinetics (DMPK) play a crucial role in the drug development process for stroke. DMPK studies involve the evaluation of how drugs are metabolized and distributed in the body, as well as how they are eliminated from the body. These studies provide important information about the safety and efficacy of a drug and help researchers determine the optimal dosing regimen for...
- Unlock the Potential of Diabetic Mouse Models in Preclinical Diabetes ResearchAce Therapeutics Diabetes, a leading provider of preclinical research services and products, is proud to announce the launch of its extensive suite of diabetic mouse models. These models have been specifically designed to enable research on different types of diabetes including type 1, type 2, and gestational diabetes, providing valuable insights into disease mechanisms and potential treatment...
- Proteomic Analysis for Glaucoma ResearchAce Therapeutics, an integrated service provider for glaucoma research, is proud to announce the release of its proteomic analysis services for glaucoma research. These cutting-edge analysis services are expected to revolutionize the way researchers approach the study of glaucoma, a leading cause of irreversible blindness worldwide. Glaucoma is a group of eye diseases characterized by...0 Комментарии 0 Поделились 1147 Просмотры 0 предпросмотр
- Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&DAce Therapeutics, a preclinical contract research organization (CRO) actively engaged in mental illness research, has announced the launch of its model development services, which aim to revolutionize psychiatric drug research and development. Psychiatric drug development is a crucial aspect of mental health treatment, as it involves the development of medications that can effectively...0 Комментарии 0 Поделились 1310 Просмотры 0 предпросмотр
Больше